AmbiCom Receives Top Assessment From Roche for Second Year in a Row
(firmenpresse) - MILPITAS, CA -- (Marketwire) -- 03/13/12 -- AmbiCom Holdings, Inc. (OTCQB: ABHI) (PINKSHEETS: ABHI), a leading designer and developer of wireless products for the medical industry, today announced that for the second year in a row it has received the highest quality assessment for its shipments to Roche Diagnostics. Annually Roche makes a quality ranking based on correct and incorrect deliveries made to them. At the end of each year, the customer determines a quality code -- those who rank in the 96% correct shipments or above are ranked an A Supplier.
AmbiCom was ranked as an A Supplier for 2011 with a quality code of 100 out of 100. "This is a significant achievement and one for which we are very, very proud to be recognized," said John Hwang, Chairman and CEO of AmbiCom.
AmbiCom is headquartered in Milpitas, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company's wireless modules and devices are based on the Company's innovative application software for both Wi-Fi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware, and to bringing new and innovative products to the wireless medical markets and other sectors. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value. For more information, visit .
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934. Although forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements, including but not limited to, our ability to maintain our website and associated computer systems, our ability to generate sufficient market acceptance for our products and services, our ability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission from time to time which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
Contact:
Bev Jedynak
Martin E. Janis & Company, Inc.
312-943-1123
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.03.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 124213
Anzahl Zeichen: 0
contact information:
Town:
MILPITAS, CA
Kategorie:
Hardware
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"AmbiCom Receives Top Assessment From Roche for Second Year in a Row"
steht unter der journalistisch-redaktionellen Verantwortung von
AmbiCom Holdings, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
